The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.
S Claiborne JohnstonPierre AmarencoHans DenisonScott R EvansAnders HimmelmannStefan JamesMikael KnutssonPer LadenvallCarlos A MolinaYongjun Wangnull nullPublished in: International journal of stroke : official journal of the International Stroke Society (2019)
http://www.clinicaltrials.gov . Unique identifier: NCT03354429.
Keyphrases
- cerebral ischemia
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- subarachnoid hemorrhage
- low dose
- atrial fibrillation
- study protocol
- phase iii
- blood brain barrier
- brain injury
- st segment elevation myocardial infarction
- phase ii
- st elevation myocardial infarction
- clinical trial
- cardiovascular events
- ischemia reperfusion injury
- coronary artery disease
- randomized controlled trial
- open label
- cardiovascular disease
- anti inflammatory drugs
- type diabetes